Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes

In patients with breast cancer, markers of aggressiveness such as dysregulation of the insulin‐like growth factor receptor (IGF1R) system and E‐cadherin loss are commonly observed. Reduced IGF1R expression is correlated with decreased E‐cadherin levels and increased cell motility. We assessed IGF1R...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mol Oncol
Hauptverfasser: Spiliotaki, Maria, Mavroudis, Dimitris, Kokotsaki, Maria, Vetsika, Eleni‐Kyriaki, Stoupis, Ioannis, Matikas, Alexios, Kallergi, Galatea, Georgoulias, Vassilis, Agelaki, Sofia
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2017
Schlagworte:
Research Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5748482/
https://ncbi.nlm.nih.gov/pubmed/28766847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12114
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge